Claritev Corporation (CTEV) Fair Value 2026

CTEV · Health Information Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.6 /10

32 fundamental signals · 2 models active

Value Trap Risk

SAFE (13/100)

Quick Summary — As of 2026-10-07, Claritev Corporation (CTEV) trades at $24.09, versus a $77.61 median fair value across its 2 active models — 222.2% above the current price. QOC: 5.6/10. Value Trap Risk: 13/100 (SAFE). 2/13 models active.

Key Facts

Ticker
CTEV
Price
$24.09
Quality Score
5.6/10
Value Trap Risk
13/100
Models Active
2/13
Last Updated
Strength: First Chicago suggests +385.8% upside with 60% confidence
Risk: Limited model coverage (2/13) may reduce confidence

Is Claritev Corporation (CTEV) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, Claritev Corporation (CTEV) appears undervalued as of : the median of 2 independent fair value estimates is $77.61, 222.2% above the current price of $24.09. Estimates range from $38.19 to $117.02. CTEV scores 5.6/10 on fundamental quality and 13/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -20.1% versus its own 13-model consensus, across 3,777 rated companies as of 2026-10-07. CTEV’s +222.2% gap is wider than that market norm, and the Health Information Services sector median is +1.2%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Claritev Corporation Stock in 2026? →

What Fair Value Does Each Model Give CTEV?

2 Intrinsic Value Models vs. Current Price ($24.09)

Core Models (Unlocked)
Model Fair Value Upside
Scenario · High Conviction
 $117.02 +385.8%
Intrinsic · High Conviction
 $38.19 +58.5%

All Models Active

All 2 models are displayed above.

What Is Claritev Corporation (CTEV) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for Claritev Corporation. Trading at $24.09 against an estimated intrinsic value of $77.61, 2 of 2 active models flag meaningful upside of +222.2% at the median. The most optimistic model, First Chicago, places fair value at $117.02 (+385.8%), while RCMH-DCF — the most conservative — estimates $38.19 (+58.5%). This +327.2% gap reflects genuine analytical uncertainty about Claritev Corporation's intrinsic worth.

What Do the Models Say About CTEV?

2 of 13 models are currently active for CTEV. All 2 active models suggest the stock trades below fair value. Taken together, their median fair value for CTEV is $77.61 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does CTEV Rank in Health Information Services?

Among 53 Health Information Services stocks, CTEV ranks #37 by Quality of Company score. CirclFi's QOC score of 5.6/10 evaluates 32 fundamental signals. A score of 5.6 reflects mixed fundamentals.

See all Most Undervalued Health Information Services Stocks →

Claritev Corporation operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is CTEV a Value Trap?

CirclFi's Value Trap algorithm assigns CTEV a score of 13/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for Claritev Corporation. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Claritev Corporation scores 5.6 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +327.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CTEV valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across CTEV's 2 active models, average confidence is 57%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Claritev Corporation Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Health Information Services Stocks Should You Also Analyze?

11 related Health Information Services stocks with 13-model coverage

AMWLAmerican Well CorporationQOC 5.8BRGXBioRegenx, Inc.QOC 5.1OMDAOmada Health, Inc.QOC 5.8ACONAclarion, Inc.QOC 5.1EVHEvolent Health, Inc.QOC 5.9MGRXMangoceuticals, Inc.QOC 4.9DOGPDogecoin Cash, Inc.QOC 4.0GDRXGoodRx Holdings, Inc.QOC 8.1SYSo-Young International Inc.QOC 6.6DOCSDoximity, Inc.QOC 9.6HQYHealthEquity, Inc.QOC 9.5

Read investment analysis: AMWL · BRGX · OMDA · ACON · EVH · MGRX · DOGP · GDRX · SY · DOCS · HQY

Which Other Stocks Have a Similar Quality Score to CTEV?

7 companies across all industries closest to CTEV’s Quality of Company score of 5.6/10.

RRGBRed Robin Gourmet Burgers, Inc.QOC 5.6ASTCAstrotech CorporationQOC 5.6PUSAPowerus CorporationQOC 5.6CDIXCardiff Lexington CorporationQOC 5.6LFWDLifeward Ltd.QOC 5.6WULFTeraWulf Inc.QOC 5.6NVDANVIDIA CorporationQOC 10.0

Read investment analysis: RRGB · ASTC · PUSA · CDIX · LFWD · WULF · NVDA

Where Does CTEV Sit in CirclFi's Health Information Services Rankings?

CTEV is ranked against every other Health Information Services stock CirclFi covers in each of these screens.

See all Health Information Services stocks ranked →

What Else Do Investors Ask About Claritev Corporation’s Valuation?

What is Claritev Corporation's intrinsic value in 2026?

CirclFi puts Claritev Corporation (CTEV)'s intrinsic value at $77.61 — the median of 2 independent model estimates as of 2026-10-07, ranging from $38.19 to $117.02. The Quality of Company score is 5.6/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CTEV overvalued or undervalued right now?

At $24.09, 2 of 2 active models suggest CTEV may be undervalued, while 0 indicate potential overvaluation. The median of all 2 fair value estimates is $77.61, 222.2% above the current price of $24.09 — a consensus view that CTEV is undervalued. The assessment depends on which methodology best fits Claritev Corporation's business model in Health Information Services.

What does a Quality of Company score of 5.6 mean for CTEV?

Claritev Corporation's QOC of 5.6/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on CTEV?

CirclFi analyzes CTEV with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is CTEV a value trap in 2026?

Claritev Corporation's Value Trap score is 13/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, Claritev Corporation (CTEV) has a median fair value of $77.61 — 222.2% above the current price of $24.09 — as of 2026-10-07.” Source: circlfi.com/stock/CTEV/ · Methodology
Primary sources for this CTEV valuation
  • Financial statements: Claritev Corporation 10-K and 10-Q filings on SEC EDGAR (CIK 0001793229) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for CTEV as of ; valuations recomputed .